Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country

Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country

Purpose: Anaplastic lymphoma kinase (ALK) inhibitors are associated with good overall survival (OS) for ALK-positive metastatic non–small cell lung cancer (NSCLC). However, these treatments can be unavailable or limited by financial constraints in developing countries. Using data from a nationwide l...

Full description

Bibliographic Details
Published in:Cancer Management and Research
Main Author: Poh M.E.; How S.H.; Ho G.F.; Pang Y.K.; Hasbullah H.H.; Tho L.M.; Nor I.M.; Lim B.C.; Ho K.F.; Thiagarajan M.; Samsudin A.; Omar A.; Ong C.K.; Soon S.Y.; Tan J.Y.K.; Abidin M.A.Z.
Format: Article
Language:English
Published: Dove Medical Press Ltd 2023
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85146472874&doi=10.2147%2fCMAR.S393729&partnerID=40&md5=04b390ab75a0d53150b544ff7882d80a

Internet

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85146472874&doi=10.2147%2fCMAR.S393729&partnerID=40&md5=04b390ab75a0d53150b544ff7882d80a

Similar Items